Rusco Pharma Private Limited

Rusco Pharma Private Limited - financial services in Mumbai, Maharashtra, India. Directors, charges & compliance details.
CIN U24230MH1994PTC080348 Incorporated 16 August 1994 ROC Mumbai HQ Mumbai, Maharashtra, India
Converted to LLP Private Limited Company financial services
Revenue · FY 2016
₹1.02 Cr
▲ 2% YoY
Net profit · FY 2016
₹49.08 Lakh
Net margin 48.1%
EBITDA · FY 2016
₹77.29 Lakh
EBITDA margin 75.8%
Authorised capital
₹5 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Satisfied charges
₹7 Cr
No open charges
Company age
32 yrs
Est. 1994
GST registrations
1
None active

About Rusco Pharma Private Limited

Data last updated:

Rusco Pharma Private Limited was a private limited company based in Mumbai, Maharashtra, India. The company has been converted to a Limited Liability Partnership (LLP) and no longer exists as a company. For the latest details, refer to the successor LLP. It operated in the real estate financing segment of the financial services sector. It was incorporated on 16 August 1994.

The company was registered with the Registrar of Companies (ROC), Mumbai, under CIN U24230MH1994PTC080348. The company has 1 GST registration on record, which is no longer active.

The company had an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh.

Its last annual general meeting (AGM) was held on 27 September 2016, and its latest financial statements are for the year ended 31 March 2016. The registered office was at Ground Floor Raghuvanshi Mansiraghuvanshi Mills Compound 9 – 11 Senapati Bapat Marg Lower, Mumbai, Maharashtra, India – 400013.

As per the financials filed for FY 2016, the company reported a revenue of ₹1.02 Cr, a growth of 2% compared to the previous year. For the same year it recorded a net profit of ₹49.08 Lakh (net margin 48.1%) and EBITDA of ₹77.29 Lakh (EBITDA margin 75.8%).

As per MCA filings, the company has satisfied charges of ₹7 Cr on record. Court records list 7 cases involving the company, including 1 filed by the company and 6 filed against it.

Company details

CIN U24230MH1994PTC080348
Registration Number 080348
Incorporation Date 16 August 1994
ROC Mumbai
Listing Status Unlisted
Company Status Converted to LLP

Contact details

Rusco Pharma Private Limited's registered office is in Mumbai, Maharashtra. Its e-mail address is in the company report.

  • Email
  • Registered Address
    Ground Floor Raghuvanshi Mansiraghuvanshi Mills Compound 9 – 11 Senapati Bapat Marg Lower, Mumbai, Maharashtra, India – 400013
  • Industry
    Financial Services, Real Estate Financing

To see the full contact details of Rusco Pharma Private Limited, buy the company report.

Comprehensive company report
Rusco Pharma Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Financials of Rusco Pharma Private Limited

FY 2016 filings available

Rusco Pharma Private Limited reported revenue of ₹1.02 Cr (up 2% YoY) for FY 2016.

Revenue · FY 2016
₹1.02 Cr ▲ 2%
Net profit · FY 2016
₹49.08 Lakh margin 48.1%
EBITDA · FY 2016
₹77.29 Lakh margin 75.8%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 2%
EBITDA CAGR growth
1 year
▼ 6%

Revenue rose 2% in the latest year. EBITDA fell 6% in the latest year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2015-16FY 2014-15
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue₹1.02 Cr
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹77.29 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)₹49.08 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2015-16FY 2014-15
Profitability
EBITDA Margin75.8%
Net Profit Margin48.1%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Rusco Pharma Private Limited, buy the company report.

Board of directors of Rusco Pharma Private Limited

Rusco Pharma has 6 former directors on record and no current directors listed.

Peer comparison

Rusco Pharma Private Limited is compared with the 10 companies closest to it by revenue in the BFSI industry (Real Estate Leasing), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Vikashni Builder Private Limited₹1.02 Cr (FY 2024)5.0%Madurai, Tamil Nadu, India
Akash Deep Private Limited₹1.02 Cr (FY 2025)8.0%Agra, Uttar Pradesh, India
Ridhima Overseas Private Limited₹1.02 Cr (FY 2025)6.0%New Delhi, Delhi, India
Kadamb Hotels Pvt Ltd₹1.02 Cr (FY 2024)2.0%Mumbai, Maharashtra, India
Goldstar Estates Private Limited₹1.02 Cr (FY 2025)3.0%New Delhi, Delhi, India
Rusco Pharma Private Limitedthis company₹1.02 Cr (FY 2016)₹49.08 Lakh48.1%2.0%Mumbai, Maharashtra, India
Garden City Foundation Private Limited₹1.02 Cr (FY 2025)121.0%Bangalore, Karnataka, India
Good Earth Constructions Private Limited₹1.02 Cr (FY 2025)1034.0%Uttar Pradesh, India
Amol Properties Private Limited₹1.02 Cr (FY 2025)-94.0%Jaipur, Rajasthan, India
Ipf Infrastructures Private Limited₹1.02 Cr (FY 2025)299.0%Chandigarh, India
Gurmat Construction Company Private Limited₹1.02 Cr (FY 2025)-11.0%New Delhi, Delhi, India

To see the full peer comparison of Rusco Pharma Private Limited, buy the company report.

Auditor

Rusco Pharma Private Limited is audited by HEMANG & BHAVEN for the financial year 2016.

Auditor firmFinancial yearFirm registration number
HEMANG & BHAVENFY 2016126071W

Shareholding

The shareholding of Rusco Pharma Private Limited is on record for 2 financial years, the latest being FY 2016, split between promoters, domestic institutions, public shareholders and others.

Shareholder categoryFY 2016FY 2015
Promoters
Domestic institutional investors (DII)
Public
Others

To see the full shareholding pattern of Rusco Pharma Private Limited, buy the company report.

Charges & borrowings

Open charges
None
Satisfied charges
₹7 Cr
Breakdown by lending institutions
Icici Bank Ltd₹7.00 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
12 Nov 201310461236Icici Bank Ltd₹7 CrSatisfied

To see the full charge records of Rusco Pharma Private Limited, buy the company report.

Total charge records: 1 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for Rusco Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Rusco Pharma has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.

Total GSTINs
1
Cancelled / inactive
1

To see the full GST registrations and return filing status of Rusco Pharma Private Limited, buy the company report.

Recent activity

Rusco Pharma Private Limited has 6 board changes on record since 2008: 0 appointments and 6 cessations. The latest: Abhishek Saraf ceased to be Director on 08 Mar 2017.

Ceased
Abhishek Saraf ceased to be Director.
Ceased
Gaurav Saraf ceased to be Director.
Ceased
Motilal Saraf ceased to be Director.
Charges
A charge registered on 12 Nov 2013 via Charge ID 10461236 with Icici Bank Ltd was fully satisfied on 27 Jan 2017.
AGM
Rusco Pharma Private Limited last Annual general meeting of members was held on 27 Sep 2016 as per latest MCA records.
Filing
Rusco Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2016 with Roc Mumbai.
Charges
A charge with Icici Bank Ltd of Rs. 700.00 Lakh registered on 12 Nov 2013 with Charge ID 10461236 was modified on 25 Dec 2013.
Charges
A charge with Icici Bank Ltd amounted to Rs. 700.00 Lakh with Charge ID 10461236 was registered on 12 Nov 2013.
Ceased
Shriram Chandak ceased to be Nominee Director.
Ceased
Subhash Bagaria ceased to be Director.
Ceased
Gauri Shankar Agarwal ceased to be Nominee Director.
Incorporation
16 Aug 1994
Rusco Pharma Private Limited was registered on 16 Aug 1994 with Roc Mumbai & aged 32 years 3 months as per MCA records.

Frequently asked questions

Rusco Pharma has been "Converted to LLP" - the business changed its legal structure from a company to a Limited Liability Partnership. The original company no longer exists in its previous form. For the latest information, refer to the successor LLP entity registered with MCA.

Rusco Pharma was a private limited company based in Mumbai, Maharashtra, India. The company worked in real estate financing, within the financial services industry. It was incorporated on 16 August 1994 and is registered under CIN U24230MH1994PTC080348. For the latest details, refer to the successor LLP entity.

The CIN (Corporate Identification Number) of Rusco Pharma is U24230MH1994PTC080348. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Rusco Pharma was incorporated on 16 August 1994. It is registered with the Registrar of Companies, Mumbai.

The registered office of Rusco Pharma is at Ground Floor Raghuvanshi Mansiraghuvanshi Mills Compound 9 – 11 Senapati Bapat Marg Lower, Mumbai, Maharashtra, India – 400013.

The latest financial statements of Rusco Pharma on record with the MCA are for the year ended 31 March 2016. Its last annual general meeting was held on 27 September 2016. Year-wise statements from 2015 are in the company report.

No. Rusco Pharma has 1 GST registration on record and it is cancelled or inactive.

Rusco Pharma operated in the financial services industry, in the real estate financing segment.

The peers of Rusco Pharma by revenue are Vikashni Builder Private Limited, Akash Deep Private Limited, Ridhima Overseas Private Limited, Kadamb Hotels Pvt Ltd, Goldstar Estates Private Limited and 5 more, all in the BFSI industry (Real Estate Leasing).

Rusco Pharma has 7 court cases on record: 1 filed by the company and 6 filed against it. Most are in the high courts.

Abhishek Saraf ceased to be Director on 08 Mar 2017. Gaurav Saraf ceased to be Director on 08 Mar 2017. Motilal Saraf ceased to be Director on 08 Mar 2017. Rusco Pharma has 6 board changes on record in total.